Composite Glucose and C-Peptide Endpoints Show Early Efficacy in Recent-Onset Type 1 Diabetes (T1D) Clinical Trials

被引：0
|
作者：
Jacobsen, Laura M.
Cuthbertson, David D.
Haller, Michael J.
Ismail, Heba M.
Sims, Emily K.
Gitelman, Stephen E.
Wherrett, Diane K.
Moran, Antoinette
Atkinson, Mark A.
Pugliese, Alberto
Gottlieb, Peter
Sosenko, Jay
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-825-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
825-P
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Age of onset of Type 1 diabetes mellitus (T1D) and the risk of complications
    Forrest, K
    Orchard, T
    DIABETES, 2000, 49 : A179 - A180
  • [42] ESTIMATING THE RISK OF DEVELOPING TYPE 1 DIABETES (T1D) THROUGH URINARY C-PEPTIDE AND ONE-WEEK HOME CGM TEST
    Montaser, E.
    Breton, M.
    Brown, S.
    Deboer, M.
    Farhy, L.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A175 - A176
  • [43] Assessments of Dysglycemia and Index60 as Pre-diagnostic Endpoints for Type 1 Diabetes (T1D) Prevention Trials
    Nathan, Brandon M.
    Atkinson, Mark A.
    Boulware, David
    Colman, Peter G.
    Geyer, Susan
    Goland, Robin S.
    Russell, William
    Wentworth, John M.
    Wilson, Darrell M.
    Moran, Antoinette
    Sosenko, Jay M.
    DIABETES, 2016, 65 : A412 - A412
  • [44] Reduced insulin clearance relates to increased liver fat content in recent-onset type 2 diabetes and to impaired glucose control in recent-onset type 1 diabetes
    Antoniou, S.
    Zaharia, O. -P.
    Bobrov, P.
    Strassburger, K.
    Karusheva, Y.
    Bodis, K.
    Kupriyanova, Y.
    Burkart, V.
    Hwang, J. -H.
    Muessig, K.
    Gastaldelli, A.
    Roden, M.
    Szendroedi, J.
    DIABETOLOGIA, 2019, 62 : S259 - S259
  • [45] Early and Later C-Peptide Responses during Oral Glucose Tolerance Testing (OGTT) Are Independently and Oppositely Predictive of Type 1 Diabetes (T1D) in Autoantibody-Positive (Ab plus ) Individuals
    Ismail, Heba M.
    Becker, Dorothy J.
    Geyer, Susan
    Xu, Ping
    Libman, Ingrid
    Herold, Kevan C.
    Atkinson, Mark A.
    Redondo, Maria J.
    Palmer, Jerry P.
    Sosenko, Jay
    DIABETES, 2018, 67
  • [46] Human leukocyte antigen class I B and C loci contribute to type 1 diabetes (T1D) susceptibility and age T1D onset
    Valdes, AM
    Erlich, HA
    Noble, JA
    HUMAN IMMUNOLOGY, 2005, 66 (03) : 301 - 313
  • [47] Opportunities to Enhance Recruitment of Youth With Type 1 Diabetes (T1D) into Continuous Glucose Monitoring (CGM) Trials
    Gaffney, Kaitlin C.
    Volkening, Lisa K.
    Barstow, Mariah M.
    Sullivan, Christina L.
    Katz, Michelle L.
    Laffel, Lori M.
    DIABETES, 2013, 62 : A228 - A229
  • [48] Impaired Insulin Clearance Relates to Increased Liver Fat Content in Recent-Onset Type 2 Diabetes and to Impaired Glucose Control in Recent-Onset Type 1 Diabetes
    Antoniou, Sofia
    Zaharia, Oana P.
    Strassburger, Klaus
    Karusheva, Yanislava
    Bodis, Kalman
    Kupriyanova, Yuliya
    Burkart, Volker
    Muessig, Karsten
    Gastaldelli, Amalia
    Roden, Michael
    Szendroedi, Julia
    DIABETES, 2019, 68
  • [49] Residual C-Peptide in Patients 3-81 Years from Diagnosis of T1D: A T1D Exchange Study
    Davis, Asa
    Haller, Michael J.
    Miller, Kellee
    Dubose, Stephanie
    Carpenter, Christina
    Dimeglio, Linda
    Liljenquist, David R.
    Ahmann, Andrew
    Marcovina, Santica M.
    Greenbaum, Carla
    Beck, Roy
    DIABETES, 2013, 62 : A422 - A423
  • [50] Effect of Exercise on Sleep and Nocturnal Glucose in Type 1 Diabetes (T1D)
    Jacobs, Peter G.
    Li, Zoey
    Calhoun, Peter
    Gal, Robin L.
    Beck, Roy
    Castle, Jessica R.
    Clements, Mark A.
    Dassau, Eyal
    Doyle, Francis J., III
    Gillingham, Melanie B.
    Martin, Corby K.
    Rickels, Michael R.
    Patton, Susana R.
    Riddell, Michael
    DIABETES, 2020, 69
12345